{"pub_date": "2016-03-12T00:00:00Z", "subsection_name": null, "lead_paragraph": "The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation.", "print_page": "2", "document_type": "article", "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "multimedia": [], "section_name": "Business Day", "headline": {"content_kicker": "Business Briefing", "print_headline": "F.D.A. Approves Drug for More Lung Cancer Patients", "main": "F.D.A. Approves Drug for More Lung Cancer Patients"}, "source": "The New York Times", "blog": [], "word_count": "117", "web_url": "http://www.nytimes.com/2016/03/12/business/fda-approves-drug-for-more-lung-cancer-patients.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a rare mutation.", "_id": "56e3603e38f0d81b768a68a2", "abstract": "Food and Drug Administration expands approval of Pfizer's Xalkori capsules, which treat small subset of lung cancer patients with rare gene mutation.", "keywords": [{"rank": "1", "name": "organizations", "value": "Food and Drug Administration", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Pfizer Inc", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Lung Cancer", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}]}